Use of Strategy Frameworks to Analyse Competitive Dynamics in the Pharmaceutical Industry

Griffiths S.B. (1963) Sun Tzu The Art of War, Oxford University Press, Oxford.

Porter M.E. (1980) Competitive Strategy. Techniques for Analyzing Industries and Competitors, Free Press, New York, NY.

Oster S.M. (1994) Modern Competitive Analysis, Oxford University Press, New York.

The Boston Consulting Group (2000) New Perspectives on Value Creation, 59.

Bastianelli E. Eckhardt J. Tierlynck O. (2001) ‘Pharma: Can the middle hold?’, McKinsey Quarterly, 1, 117–125.

Lehman Brothers (2002) Pharma Pipelines, Lehman Brothers, London, UK.

Lehman Brothers (2003) Rx Insight 2003, Lehman Brothers Global Equity Research, New York, NY.

Agrawal M. (1999) Global Competitiveness in the Pharmaceutical Industry. Haworth Press, Binghamton, NY.

Lehman Brothers (2003) op. cit..

Hunt M.S. (1972) Competition in the Major Home Appliance Industry, 1960–1970, Harvard University, Cambridge, MA.

Bain J.S. (1968) Industrial Organisation, 2nd edn. John Wiley, New York, NY.

Mason E. (1949) ‘The current state of the monopoly problem in the US’, Harvard Law Review, 62, 1265–1285.

Porter (1980) op. cit..

Porter (1980) op. cit., 127–128.

McKelvey B. (1982) Organizational Systematics. Taxonomy, Evolution, Classification, University of California Press, Los Angeles, CA.

Ibid..

Caves R.E. Porter M.E. (1977) ‘From entry barriers to mobility barriers: Conjectual decisions and contrived deterrence to new competition’, Quarterly Journal of Economics, 91, 241–261.

Porter M.E. (1973) Consumer Behavior, Retailer Power, and Manufacturer Strategy in Consumer Goods Industries, Harvard University, Cambridge, MA.

Porter M.E. (1976) Interbrand Choice, Strategy, and Bilateral Market Power, Harvard Economics Studies. Harvard University Press, Cambridge, MA.

Porter M.E. (1979) ‘The structure within industries and companies' performance’, Review of Economics and Statistics, May, 602–613.

Caves Porter (1977) op. cit..

McGee J. (2003) ‘Strategic groups: Theory and practice’, in Faulkner D.O. Campbell A. (eds) The Oxford Handbook of Strategy: A Strategy Overview and Competitive Strategy. Oxford University Press, Oxford, UK, 261–301.

Burleigh J. (2003) ‘NHS to sue seven drug firms for fixing price of medicines’, The Independent, 22 December, London.

Fiegenbaum A. Thomas H. (1995) ‘Strategic groups as reference groups: Theory, modeling and empirical examination of industry and competitive strategy’, Strategic Management Journal, 16, 461–476.

McNamara G. Deephouse D.L. Luce R.A. (2003) ‘Competitive positioning within and across a strategic group structure: The performance of core, secondary and solitary firms’, Strategic Management Journal, 24, 161–181.

Caves Porter (1977) op. cit..

McGee J. Thomas H. (1986) ‘Strategic groups: Theory, research and taxonomy’, Strategic Management Journal, March-April, 141–160.

McGee (2003) op. cit..

McGee (2003) op. cit..

Mascarenhas B. Aaker D.A. (1989) ‘Mobility barriers and strategic groups’, Strategic Management Journal, 10, 475–485.

Porter (1976) op. cit..

Porter (1979) op. cit..

Dranove D. Peteraf M.A. Shanley M. (1998) ‘Do strategic groups exist? An economic framework for analysis’, Strategic Management Journal, November, 1029–1044.

McNamara (2003) op. cit..

Leask G. Parker D. (2003) ‘An application of strategic group theory to the UK pharmaceutical industry. Aston Working Paper, Birmingham, 1–17.

Miles R.E. Snow C.C. (1978) Organizational Strategy, Structure and Process, McGraw Hill, New York, NY.

Hawes J. Crittenden W. (1984) ‘A taxonomy of competitive retailing strategies’, Strategic Management Journal, July-September, 275–287.

Porter (1980) op. cit..

Miles and Snow (1978) op. cit..

Porter (1980) op. cit..

Porter (1980) op. cit..

Porter (1980) op. cit..

Hawthorne F. (2003) The Merck Druggernaut: The Inside Story of a Pharmaceutical Giant, John Wiley & Sons, Chichester, UK.